RadNet Beheer

Beheer criteriumcontroles 2/4

De CEO RadNet is Howard Berger, benoemd in Jan1987, heeft een ambtstermijn van 37.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.70M, bestaande uit 22.4% salaris en 77.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.34% van de aandelen van het bedrijf, ter waarde € 18.90M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.9 jaar en 12.3 jaar.

Belangrijke informatie

Howard Berger

Algemeen directeur

US$6.7m

Totale compensatie

Percentage CEO-salaris	22.4%
Dienstverband CEO	37.8yrs
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	10.9yrs
Gemiddelde ambtstermijn bestuur	12.3yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Howard Berger's beloning veranderd ten opzichte van RadNet's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$4m
Jun 30 2024	n/a	n/a	US$10m
Mar 31 2024	n/a	n/a	US$21m
Dec 31 2023	US$7m	US$2m	US$3m
Sep 30 2023	n/a	n/a	US$4m
Jun 30 2023	n/a	n/a	-US$13m
Mar 31 2023	n/a	n/a	-US$13m
Dec 31 2022	US$6m	US$2m	US$11m
Sep 30 2022	n/a	n/a	US$8m
Jun 30 2022	n/a	n/a	US$23m
Mar 31 2022	n/a	n/a	US$18m
Dec 31 2021	US$5m	US$1m	US$25m
Sep 30 2021	n/a	n/a	US$35m
Jun 30 2021	n/a	n/a	US$24m
Mar 31 2021	n/a	n/a	US$11m
Dec 31 2020	US$3m	US$783k	-US$15m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	-US$13m
Mar 31 2020	n/a	n/a	US$2m
Dec 31 2019	US$3m	US$1m	US$15m
Sep 30 2019	n/a	n/a	US$33m
Jun 30 2019	n/a	n/a	US$35m
Mar 31 2019	n/a	n/a	US$36m
Dec 31 2018	US$3m	US$1m	US$32m
Sep 30 2018	n/a	n/a	-US$4m
Jun 30 2018	n/a	n/a	-US$6m
Mar 31 2018	n/a	n/a	-US$6m
Dec 31 2017	US$2m	US$700k	US$53k

Compensatie versus markt: De totale vergoeding ($USD 6.70M ) Howard } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 3.50M ).

Compensatie versus inkomsten: De vergoeding van Howard is gestegen terwijl het bedrijf verliesgevend is.

CEO

Howard Berger (78 yo)

37.8yrs

Tenure

US$6,700,183

Compensatie

Dr. Howard G. Berger, M.D., serves as the President and Chief Financial Officer of Image Medical Corporation. Dr. Berger has been the Chief Executive Officer and President at RadNet, Inc. and its predecess...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Howard Berger	Chairman	37.8yrs	US$6.70m	0.34% € 18.9m
Mark Stolper	Executive VP & CFO	20.3yrs	US$1.90m	0.11% € 6.1m
A. Sorensen	Executive VP	1.3yrs	US$1.80m	1.7% € 94.9m
Mital Patel	Executive VP of Financial Planning & Analysis and Chief Administrative Officer	3.8yrs	US$1.92m	0.27% € 15.3m
Norman Hames	President & COO of Western Operations	no data	US$2.14m	0.31% € 17.4m
Stephen Forthuber	President & COO of Eastern Operations	7.5yrs	US$2.16m	0.68% € 38.3m
Christine Gordon	Senior VP of Operations of Northern California	no data	US$564.98k	0.015% € 822.6k
Ranjan Jayanathan	Executive VP	14.2yrs	geen gegevens	0.31% € 17.3m
Laura Foster	Senior Vice President of Compliance & Regulatory Affairs	7.7yrs	geen gegevens	geen gegevens
David Katz	Executive VP	4.7yrs	geen gegevens	0.10% € 5.7m
Michael Murdock	Executive Vice President of Mergers & Acquisitions	17.8yrs	geen gegevens	0.065% € 3.6m
Derek Bomar	Senior VP & Director of Materials & Asset Management	21.8yrs	geen gegevens	geen gegevens

10.9yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van PQIA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.9 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Howard Berger	Chairman	32.8yrs	US$6.70m	0.34% € 18.9m
A. Sorensen	Executive VP	1.3yrs	US$1.80m	1.7% € 94.9m
David Swartz	Lead Independent Director	20.8yrs	US$244.99k	0.32% € 17.8m
Gregory Spurlock	Independent Director	3.4yrs	US$207.49k	0.0035% € 195.9k
Lawrence Levitt	Independent Director	19.8yrs	US$224.99k	0.23% € 13.1m
Laura Jacobs	Independent Director	4.8yrs	US$222.49k	0.033% € 1.8m

12.3yrs

Gemiddelde duur

72.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PQIA zijn ervaren en ervaren (gemiddelde ambtstermijn van 12.3 jaar).

RadNet Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

Insider recently sold €846k worth of stock

Insufficient new directors

Executive VP recently sold €930k worth of stock

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Insider recently sold €328k worth of stock

Recent updates

Third quarter 2024 earnings released: EPS: US$0.044 (vs US$0.26 in 3Q 2023)

RadNet, Inc. Revises Earnings Guidance for the Year 2024

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

Insider recently sold €846k worth of stock

Second quarter 2024 earnings released: US$0.041 loss per share (vs US$0.14 profit in 2Q 2023)

New minor risk - Share price stability

Insufficient new directors

Executive VP recently sold €930k worth of stock

First quarter 2024 earnings released: US$0.04 loss per share (vs US$0.36 loss in 1Q 2023)

RadNet, Inc., Annual General Meeting, Jun 12, 2024

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Now 23% overvalued after recent price rise

Full year 2023 earnings released: EPS: US$0.048 (vs US$0.19 in FY 2022)

Insider recently sold €328k worth of stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.012 in 3Q 2022)

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2022)

Radnet, Inc. Revises Earnings Guidance for the Year 2023

RadNet, Inc. Announces Appointment of Executives

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold €1.3m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

Board Member recently sold €128k worth of stock

RadNet, Inc., Annual General Meeting, Jun 07, 2023

RadNet, Inc. Revises Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.36 loss per share (vs US$0.054 profit in 1Q 2022)

President & COO of Eastern Operations recently sold €217k worth of stock

Insider recently sold €418k worth of stock

Full year 2022 earnings released: EPS: US$0.19 (vs US$0.47 in FY 2021)

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold €92k worth of stock

Third quarter 2022 earnings released: EPS: US$0.012 (vs US$0.31 in 3Q 2021)

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: US$0.14 (vs US$0.055 in 2Q 2021)

RadNet, Inc. Updates Earnings Guidance for 2022

President & COO of Western Operations recently sold €193k worth of stock

RadNet, Inc. Announces That It Has Received FDA Clearances for Its DeepHeatlh Saige-DX™ Mammography and Quantib® Prostate 2.0 MRI Artificial Intelligence ("Ai") Algorithms

First quarter 2022 earnings released: EPS: US$0.054 (vs US$0.18 in 1Q 2021)

RadNet, Inc. Revises Earnings Guidance for the Fiscal Year 2022

RadNet, Inc., Annual General Meeting, Jun 08, 2022

RadNet, Inc. Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

RadNet, Inc. (NasdaqGM:RDNT) acquired Quantib B.V. for $45 million.

Third quarter 2021 earnings released: EPS US$0.31 (vs US$0.12 in 3Q 2020)

Senior VP of Human Resources & Director recently sold €86k worth of stock

Investor sentiment deteriorated over the past week

Lead Independent Director recently bought €129k worth of stock

Second quarter 2021 earnings released: EPS US$0.055 (vs US$0.21 loss in 2Q 2020)

Senior VP of Human Resources & Director recently sold €388k worth of stock

Independent Director Marvin Cadwell has left the company

VP, Medical Director & Director John Crues has left the company

Insider recently sold €404k worth of stock

Independent Director recently bought €238k worth of stock

First quarter 2021 earnings released: EPS US$0.18 (vs US$0.33 loss in 1Q 2020)

RadNet, Inc. Revises Earnings Guidance for the Year 2021

Independent Director recently sold €397k worth of stock

Full year 2020 earnings released: US$0.29 loss per share (vs US$0.30 profit in FY 2019)

Revenue beats expectations

New 90-day high: €19.90

RadNet and its Partner Dignity Health, Plaza Companies and Holualoa Companies Team Up to Redevelop Park Central

New 90-day high: €17.00

President & COO of Western Operations recently sold €236k worth of stock